Knightscope, Inc. (NASDAQ: KSCP) is making a broader case than “robots on patrol.” With record second-quarter revenue, an expanding national client base, new AI-driven security capabilities and an integrated model that joins autonomous machines with trained human professionals, the company is positioning itself…
NVIDIA Corp. (NASDAQ: NVDA) has spent the past several years selling the shovels for the artificial-intelligence gold rush. Its planned $12.93 billion acquisition of Hugging Face suggests it now wants a more influential place in the mine, the marketplace and perhaps the…
AGNT, Inc. (NASDAQ: AGNT) has added another data point to its agent-attraction narrative: Fresno-based Tafoya Real Estate, a 37-agent California mega team with $87.92 million in sales volume across 172 transaction sides in 2024 and 2025, has moved to eXp Realty from…
FMC Corporation (NYSE: FMC) heads into the 2026 Jefferies Global Industrials Conference with a story that is no longer about simply enduring a difficult crop-protection cycle. It is increasingly about balance-sheet repair, portfolio renewal and the possibility that a battered agricultural-sciences franchise is…
Yatsen Holding Limited (NYSE: YSG) is approaching a consequential earnings date with a more compelling narrative than the market may be pricing in: a China beauty platform shifting from online color-cosmetics challenger to science-led, premium omnichannel operator. Its partnership to place Perfect Diary…
The biotechnology market has a habit of demanding patience right up until it abruptly decides to reward it. Moderna, Inc. (NASDAQ: MRNA) recently reminded investors of that rule as enthusiasm around its personalized melanoma-vaccine program with Merck & Co., Inc. (NYSE: MRK)…
For patients with eosinophilic esophagitis, eating can become an exercise in calculated risk rather than a simple pleasure. For Eupraxia Pharmaceuticals Inc. (NASDAQ: EPRX; TSX: EPRX), that burden represents both an urgent medical problem and a potentially compelling opportunity to prove that…
FIGS, Inc. (NYSE: FIGS) just delivered the kind of quarter that reminds investors why “boring” healthcare can quietly become a growth stock thriller—no meme magic required, just rising margins, disciplined execution, and a growing global tribe of loyal customers.
Healthcare Couture Gets…
Doximity, Inc. (NYSE: DOCS) shares sold off into the close today but then staged a sharp rebound in the after‑hours session, with the stock surging more than 60 percent off its regular‑session levels as investors reassessed the company’s fiscal 2027 first‑quarter results…
Amwell (NYSE: AMWL) is trying to do something rare in healthcare technology: become more interesting by becoming less dramatic. After years of telehealth hype, backlash, and normalization, the company’s latest setup suggests a business leaning into discipline, enterprise relevance, and just enough…
